How should I manage a female patient with noticeably increased ear pressure likely due to eustachian‑tube blockage from an upper‑respiratory infection or sinus congestion?

Management of Increased Ear Pressure from Eustachian Tube Blockage

For a female patient with increased ear pressure from eustachian tube blockage secondary to upper respiratory infection or sinus congestion, initiate treatment with intranasal corticosteroid spray (such as mometasone furoate) combined with regular Valsalva maneuvers, while avoiding nasal decongestants which have not been shown to improve eustachian tube function.

Initial Assessment and Diagnosis

First, confirm eustachian tube dysfunction (ETD) through:

• Pneumatic otoscopy to assess tympanic membrane mobility (minimal or sluggish movement suggests middle ear fluid) 1
• Tympanometry to objectively measure middle ear pressure (flat tracing indicates fluid; shifted peak indicates pressure abnormality) 1
• ETDQ-7 questionnaire (score ≥15 indicates clinically significant ETD) 2, 3

The correlation between nasal obstruction severity and ETD symptoms is strong (r=0.5124), so assess the degree of nasal congestion 2.

Evidence-Based Treatment Algorithm

First-Line Medical Management

Intranasal corticosteroids are the cornerstone of treatment:

• Use mometasone furoate nasal spray or equivalent steroid nasal spray 2, 3
• After 1 month of treatment, AR patients showed significant improvement in ETDQ-7 scores (p<0.0001) and objective eustachian tube function on tubomanometry (p<0.0001) 2
• The pharyngeal orifices of the eustachian tubes respond well to topical corticosteroid therapy 2

Regular Valsalva maneuvers should be performed alongside steroid therapy 3

What NOT to Use

Avoid nasal decongestants (such as xylometazoline):

• A prospective study of 24 patients (44 ears) with intact eardrums and 39 patients (43 ears) with perforated eardrums found that nasal decongestants had no effect on eustachian tube opening in most cases 4
• In some patients, decongestants actually reduced ET function 4
• This contradicts common clinical practice but represents the best available evidence

Delivery Method Considerations

If using intranasal corticosteroids, consider:

• Exhalation delivery systems (EDS) provide significantly better nasopharyngeal and ET orifice distribution compared to conventional nasal sprays (OR 3.49 for nonsurgical patients, p=0.021) 5
• This may enhance therapeutic efficacy for ETD specifically

Expected Timeline and Outcomes

• Most OME episodes resolve spontaneously within 3 months 1
• With appropriate treatment (intranasal steroids + antihistamines if allergic component), expect significant improvement within 1 month 2
• If symptoms persist beyond 3 months despite medical management, consider referral to ENT for evaluation 1

Important Caveats

Avoid air travel during acute phase:

• A case report demonstrates the severe consequences of flying with blocked eustachian tubes: tympanic membrane rupture, permanent sensorineural hearing loss, and prolonged vertigo 6
• Advise patients to postpone non-essential flights until symptoms resolve

Monitor for complications:

• Persistent middle ear fluid (>3 months) can cause conductive hearing loss, balance problems, and structural tympanic membrane damage 1
• About 30-40% of patients have repeated episodes 1

Consider underlying causes:

• If allergic rhinitis is present, add oral antihistamine (loratadine or equivalent) to the intranasal steroid 2
• The combination significantly improves both nasal symptoms and eustachian tube function 2

When to Escalate Care

Refer to ENT if:

• Symptoms persist >3 months despite appropriate medical therapy 1
• Hearing loss develops or worsens
• Structural changes to tympanic membrane occur
• Recurrent episodes significantly impact quality of life

The evidence strongly supports medical management as first-line therapy, with intranasal corticosteroids showing objective improvement in eustachian tube function, while decongestants lack efficacy despite their widespread use 2, 4.